Current database content for version 2026.4 released 17 November 2026.
| Target Class | Number of human targets‡ |
| 7TM receptors | 400 |
| G protein-coupled receptors including orphans | 396 |
| Orphan G protein-coupled receptors* | 41 |
| Other 7TM proteins | 4 |
| Nuclear hormone receptors | 48 |
| Catalytic receptors | 253 |
| Ligand-gated ion channels | 81 |
| Voltage-gated ion channels | 144 |
| Other ion channels | 55 |
| Enzymes | 1334 |
| Transporters | 555 |
| Other protein targets | 277 |
| Total number of targets | 3147 |
| Chemical Class | Number of ligands |
| Synthetic organics | 9878 |
| Metabolites | 514 |
| Endogenous peptides | 842 |
| Other peptides including synthetic peptides | 1625 |
| Natural Products | 560 |
| Antibodies | 511 |
| Inorganics | 39 |
| Approved drugs | 2257 |
| Withdrawn drugs | 123 |
| Drugs with INNs | 4066 |
| Labelled ligands | 662 |
| Total number of ligands | 14048 |
| Category | Count in database |
| Total curated interactions | 25004 |
| Total quantitative interactions | 22686 |
| Number of unique target-ligand pairs | 20514 |
| Number of curated binding constants | 22686 |
| Number of binding constants from large-scale screens | 31207 |
| Number of references | 50658 |
| Human targets with curated interactions | 2101 |
| Human targets with quantitative interactions | 1837 |
| Human targets with quantitative interactions with CIDs | 1653 |
| Human targets of approved drugs | 783 |
| Human primary targets of approved drugs | 362 |
| Approved drugs with quantitative interactions | 1281 |
| Ligands with target interactions | 11455 |
| Ligands with quantitative interactions | 10096 |
| Ligands with CID and quantitative interactions | 8553 |
| Ligands with clinical use summary | 4446 |
| Approved drugs with clincial use summary | 2254 |
There should be some charts here, you may need to enable JavaScript!
‡ Measured by the number of distinct human UniProt entries included in the database for a given target class.
* Orphans are defined as proteins having similarity to receptors but whose endogenous ligands have not yet been conclusively identified.